ERBB2 and breast cancer: We defined molecular subtypes of breast cancer based on recognized methods,12, 19 including 73 cases of luminal A subtype, 398 cases of luminal B subtype, 89 cases of HER2‐overexpressing subtype, and 72 cases of triple‐negative subtype.